“Is there a better therapeutic time window from diagnosis to treatment elderly acute myeloid leukemia patients receiving hypomethylating agents?” (2024) Mediterranean Journal of Hematology and Infectious Diseases, 16(1), p. e2024055. doi:10.4084/MJHID.2024.055.